7NEWS: Australia's TGA Clears Foundayo, the Second GLP-1 Weight-Loss Pill After the Wegovy Pill
Australia's Therapeutic Goods Administration has cleared Lilly's daily Foundayo pill for weight management and type 2 diabetes, 7NEWS reported on November 17 Australian time, weeks after the Wegovy pill was approved. It is available by private prescription but not yet listed on the Pharmaceutical Benefits Scheme, and Lilly Australia said trials enrolled more than 10,000 patients in 15 countries. Associate Professor Samantha Hocking said obesity and overweight now affect around 13 million Australian adults.